BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 26703441)

  • 21. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy.
    Tchetina EV; Di Battista JA; Zukor DJ; Antoniou J; Poole AR
    Arthritis Res Ther; 2007; 9(4):R75. PubMed ID: 17683641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dkk-1 promotes angiogenic responses and cartilage matrix proteinase secretion in synovial fibroblasts from osteoarthritic joints.
    Weng LH; Ko JY; Wang CJ; Sun YC; Wang FS
    Arthritis Rheum; 2012 Oct; 64(10):3267-77. PubMed ID: 22736200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
    Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
    Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response.
    Furuzawa-Carballeda J; Macip-Rodríguez PM; Cabral AR
    Clin Exp Rheumatol; 2008; 26(4):554-60. PubMed ID: 18799084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glatiramer acetate (GA), the immunomodulatory drug, inhibits inflammatory mediators and collagen degradation in osteoarthritis (OA) cartilage.
    Attur M; Millman JS; Dave MN; Al-Mussawir HE; Patel J; Palmer G; Abramson SB
    Osteoarthritis Cartilage; 2011 Sep; 19(9):1158-64. PubMed ID: 21745583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation.
    Neidhart M; Hauser N; Paulsson M; DiCesare PE; Michel BA; Häuselmann HJ
    Br J Rheumatol; 1997 Nov; 36(11):1151-60. PubMed ID: 9402858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitogen-activated protein kinase-activated protein kinase 2 (MK2) modulates key biological pathways associated with OA disease pathology.
    Jones SW; Brockbank SM; Clements KM; Le Good N; Campbell D; Read SJ; Needham MR; Newham P
    Osteoarthritis Cartilage; 2009 Jan; 17(1):124-31. PubMed ID: 18562219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis.
    Lohmander LS; Atley LM; Pietka TA; Eyre DR
    Arthritis Rheum; 2003 Nov; 48(11):3130-9. PubMed ID: 14613275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation.
    Xue M; McKelvey K; Shen K; Minhas N; March L; Park SY; Jackson CJ
    Rheumatology (Oxford); 2014 Dec; 53(12):2270-9. PubMed ID: 24982240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of soluble 14-3-3∊ as a novel subchondral bone mediator involved in cartilage degradation in osteoarthritis.
    Priam S; Bougault C; Houard X; Gosset M; Salvat C; Berenbaum F; Jacques C
    Arthritis Rheum; 2013 Jul; 65(7):1831-42. PubMed ID: 23552998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage.
    Patel L; Sun W; Glasson SS; Morris EA; Flannery CR; Chockalingam PS
    BMC Musculoskelet Disord; 2011 Jul; 12():164. PubMed ID: 21762512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lithium protects against cartilage degradation in osteoarthritis.
    Minashima T; Zhang Y; Lee Y; Kirsch T
    Arthritis Rheumatol; 2014 May; 66(5):1228-36. PubMed ID: 24470226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB.
    Singh R; Ahmed S; Islam N; Goldberg VM; Haqqi TM
    Arthritis Rheum; 2002 Aug; 46(8):2079-86. PubMed ID: 12209512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products.
    DeGroot J; Verzijl N; Wenting-Van Wijk MJ; Bank RA; Lafeber FP; Bijlsma JW; TeKoppele JM
    Arthritis Rheum; 2001 Nov; 44(11):2562-71. PubMed ID: 11710713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The chemokine CCL20 induces proinflammatory and matrix degradative responses in cartilage.
    Alaaeddine N; Antoniou J; Moussa M; Hilal G; Kreichaty G; Ghanem I; Abouchedid W; Saghbini E; Di Battista JA
    Inflamm Res; 2015 Sep; 64(9):721-31. PubMed ID: 26189947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
    Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
    Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased CD40 expression on articular chondrocytes from patients with rheumatoid arthritis: contribution to production of cytokines and matrix metalloproteinases.
    Gotoh H; Kawaguchi Y; Harigai M; Hara M; Saito S; Yamaguchi T; Shimada K; Kawamoto M; Tomatsu T; Kamatani N
    J Rheumatol; 2004 Aug; 31(8):1506-12. PubMed ID: 15290728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The serine protease inhibitor trappin-2 is present in cartilage and synovial fluid in osteoarthritis.
    Jaovisidha K; Etim A; Yamakawa K; Masuda I; Gohr CM; Wakim BT; Boonapatcharoen N; Ninomiya J; Rosenthal AK
    J Rheumatol; 2006 Feb; 33(2):318-25. PubMed ID: 16465664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor alpha suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis.
    Appleton CT; Usmani SE; Bernier SM; Aigner T; Beier F
    Arthritis Rheum; 2007 Nov; 56(11):3693-705. PubMed ID: 17968906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.